(Q37779059)

23 August 2017

title

Impact of statin therapy on survival in epithelial ovarian cancer (English)

1 reference

23 August 2017

1 reference

1 reference

R Geoffrey Elmore

1

1 reference

23 August 2017

Yevgeniya Ioffe

2

1 reference

23 August 2017

Daniel R Scoles

3

1 reference

23 August 2017

Beth Y Karlan

4

1 reference

23 August 2017

Andrew J Li

5

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

23 August 2017

1 reference

23 August 2017

volume

111

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

102-105

1 reference

Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

National trends in statin use by coronary heart disease risk category

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Statin use and risk of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Statins, fibrates, and melanoma risk: a systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Statin use and breast cancer: prospective results from the Women's Health Initiative.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

The association between statins and cancer incidence in a veterans population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Statin drugs and risk of advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Lovastatin-induced apoptosis in human melanoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Growth inhibition of neuroblastoma cells by lovastatin and L-ascorbic acid is based on different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (pravastatin) inhibits endothelial cell proliferation dependent on G1 cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Simvastatin potentiates TNF-alpha-induced apoptosis through the down-regulation of NF-kappaB-dependent antiapoptotic gene products: role of IkappaBalpha kinase and TGF-beta-activated kinase-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.007

10.1016/J.YGYNO.2008.06.007

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference